Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.

Hausmaninger, Hubert; Morack, Günter; Heinrich, Bernhard; Wallwiener, Diethelm; Höffken, Klaus; Buksmaui, Sarwat; Krejcy, Kurt; Miller, Mary Alice; Possinger, Kurt

Hausmaninger, Hubert; Morack, Günter; Heinrich, Bernhard; Wallwiener, Diethelm; Höffken, Klaus; Buksmaui, Sarwat; Krejcy, Kurt; Miller, Mary Alice; Possinger, Kurt.

Affiliation

Hausmaninger H; Landeskrankenanstalten Salzburg, Salzburg, Austria. H.Hausmaninger@lks.at

Am J Clin Oncol ; 27(4): 429-35, 2004 Aug.

Article in En | MEDLINE | ID: mdl-15289740

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Carcinoma, Ductal, Breast/drug therapy; Carcinoma, Lobular/drug therapy; Deoxycytidine/analogs & derivatives; Adult; Aged; Breast Neoplasms/pathology; Carcinoma, Ductal, Breast/secondary; Carcinoma, Lobular/secondary; Deoxycytidine/administration & dosage; Epirubicin/administration & dosage; Female; Humans; Middle Aged; Neoplasm Metastasis; Survival Analysis; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Lobular / Carcinoma, Ductal, Breast / Deoxycytidine Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Am J Clin Oncol Year: 2004 Type: Article Affiliation country: Austria

Search on Google

Add to My VHL

XML

PubMed Links